To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The deal to buy the maker of ...

Despite a daily loss of 5.03% and a 3-month gain of 18.51%, Axonics Inc (NASDAQ:AXNX) recorded a Loss Per Share of 0.67. This raises the question - is the stock significantly undervalued? In this ...

Axonics (NASDAQ:AXNX) stock is rising higher on Monday following news that Boston Scientific (NYSE:BSX) is acquiring the company for $3.7 billion. That has Boston Scientific agreeing to purchase ...

On September 22, 2023, Axonics Inc (NASDAQ:AXNX) reported a 1.95% daily loss, bringing its 3-month gain to 8.53%. Despite a Loss Per Share of $0.67, the question arises: is the stock significantly ...

Boston Scientific Corporation (NYSE:BSX) has agreed to acquire Axonics Inc (NASDAQ: AXNX) for $71 in cash per share, representing an enterprise value of approximately $3.4 billion and an equity value ...

Based in Irvine, device maker Axonics Inc. reported fourth-quarter revenue climbed 61% to $85.6 million to $86 million, topping the $78.1 million expected by analysts. “This quarter’s record revenue ...

Over the past 3 months, 12 analysts have published their opinion on Axonics (NASDAQ:AXNX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a ...

IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) today announced that it has received notice that Medtronic has filed a complaint with the U.S. International Trade Commission (ITC), along ...

Boston Scientific said it will buy Axonics, a device company treating urinary and bowel disorders, on Monday. The deal is worth $3.7 billion. It’s the first billion-dollar medical device deal of 2024 ...

Axonics Modulation Technologies Inc. (Nasdaq: AXNX) of Irvine said the U.S. Patent and Trademark Office’s decision to review six of seven patent claims from competitor Medtronic PLC (NYSE: MDT) on ...

IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel ...

Axonics is a medical device company that focuses on bladder and bowel dysfunction therapies. The company also upgraded its annual revenue guidance. Axonics recently won on appeal in a patent fight ...